Pre-school wheeze: More questions than answers

Pediatric Pulmonology

Volumn 41, Issue 10, 2006, Pages 910-911

  Gappa, Monika ^a   Bush, Andrew ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; MACROLIDE; NITRIC OXIDE;

ASTHMA; ATOPY; COUGHING; DIAGNOSTIC TEST; HUMAN; LUNG FUNCTION TEST; NOTE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL BACKGROUND; WHEEZING;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; RESPIRATORY SOUNDS;

EID: 33749579653     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20495     Document Type: Note

References (17)

1. Fujitani Y, Trifilieff A. In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am J Respir Crit Care Med 2003;167:193-198.
2. Bush A, Rubin BK. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2003;24:737-748.
3. Chauliac ES, Silverman M, Zwahlen M, Strippoli M-PF, Brooke AM, Kuehni CE. The therapy of pre-school wheeze: Appropriate and fair? Pediatr Pulmonol 2006;41:829-838.
4. Nystad W, Samuelsen SO, Nafstad P, Edvardsen E, Stensrud T, Jaakkola JJ. Feasibility of measuring lung function in preschool children. Thorax 2002;57:1021-1027.
5. Crenesse D, Berlioz M, Bourrier T, Albertini M. Spirometry in children aged 3 to 5 years: Reliability of forced expiratory maneuvers. Pediatr Pulmonol 2001;32:56-61.
6. McKenzie SA, Chan E, Dundas I, Bridge PD, Pao CS, Mylonopoulou M, Healy MJ. Airway resistance measured by the interrupter technique: Normative data for 2-10 year olds of three ethnicities. Arch Dis Child 2002;87:248-251.
7. Kozlowska WJ, Aurora P. Spirometry in the pre-school age group. Paediatr Respir Rev 2005;6:267-272.
8. Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, Bush A. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med 2004;169:1152-1159.
9. Gustafsson PM. Inert gas washout in preschool children. Paediatr Respir Rev 2005;6:239-245.
10. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-322.
11. Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, Taussig LM, Wright AL, Martinez FD. Outcome of asthma and wheezing in the first 6 years of life: Follow-up through adolescence. Am J Respir Crit Care Med 2005;172:1253-1258.
12. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002;109:189-194.
13. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117.
14. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-138.
15. Saglani S, Malmstrom K, Pelkonen AS, Malmberg LP, Lindahl H, Kajosaari M, Turpeinen M, Rogers AV, Payne DN, Bush A, Haahtela T, Makela MJ, Jeffery PK. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-727.
16. Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergada I. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatr Pulmonol 2004;37:111-115.
17. Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med 2005;171:587-590.